- Home
- NATR vs DRTS Comparison
NATR vs DRTS Comparison
Compare NATR & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NATR | DRTS |
|---|---|---|
| Founded | 1972 | 2015 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 389.1M | 445.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NATR | DRTS |
|---|---|---|
| Price | $22.59 | $7.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $21.33 | $8.00 |
| AVG Volume (30 Days) | 86.0K | ★ 319.3K |
| Earning Date | 11-06-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.80 | N/A |
| Revenue | ★ $474,542,000.00 | N/A |
| Revenue This Year | $7.30 | N/A |
| Revenue Next Year | $3.44 | N/A |
| P/E Ratio | $27.67 | ★ N/A |
| Revenue Growth | ★ 6.62 | N/A |
| 52 Week Low | $11.01 | $2.30 |
| 52 Week High | $24.12 | $7.89 |
Technical Indicators
Market Signals| Indicator | NATR | DRTS |
|---|---|---|
| Relative Strength Index (RSI) | 60.81 | 78.12 |
| Support Level | $21.88 | $6.45 |
| Resistance Level | $23.05 | $5.14 |
| Average True Range (ATR) | 0.77 | 0.50 |
| MACD | -0.02 | 0.20 |
| Stochastic Oscillator | 80.28 | 92.04 |
Price Performance
Historical ComparisonAbout NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.